Brazilian HTA drive "a challenge", says Anvisa quality assurance expert
This article was originally published in Clinica
Executive Summary
“The implantation of health technology assessment (HTA) in Brazil is proving to be a challenge,” according to Clarice Petramale, co-ordinator of the vigilance unit of regulatory agency Anvisa, in comments appraising current efforts to improve purchasing quality and cost-effectiveness. She was speaking at the 10th “sentinel hospitals” conference, in São Paulo, which was centred on the themes of HTA and patient safety.